Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

NCT04535167 ·Status: COMPLETED ·Phase: PHASE1

Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older

NCT04798027 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

NCT06006559 ·Status: RECRUITING ·Phase: PHASE2

The Efficacy and Safety of Azovudine in the Treatment of COVID-19

NCT05675761 ·Status: UNKNOWN

Safety, Tolerability and Blood Sampling of GSK3923868 Administered Via Dry Powder Inhaler to Healthy Participants of Chinese, Japanese and European Ancestry

NCT06577597 ·Status: COMPLETED ·Phase: PHASE1

Investigational Therapeutics for the Treatment of People With Ebola Virus Disease

NCT03719586 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older

NCT04405076 ·Status: COMPLETED ·Phase: PHASE2

BLU-5937: First-in-Human, Single and Multiple Doses Escalation, Safety, Tolerability, Pharmacokinetics and Food Effect

NCT03638180 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

NCT06679140 ·Status: RECRUITING ·Phase: PHASE3

EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19

NCT04960202 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

NCT05677893 ·Status: COMPLETED ·Phase: PHASE1

Study of HS-10517 in Chinese Adult Participants

NCT05779579 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection

NCT03376321 ·Status: TERMINATED ·Phase: PHASE3

Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness

NCT05603143 ·Status: TERMINATED ·Phase: PHASE3

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

NCT01593072 ·Status: WITHDRAWN ·Phase: PHASE1

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

NCT04359680 ·Status: COMPLETED ·Phase: PHASE3

A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19

NCT04582318 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

NCT03679143 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19

NCT05633433 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Trial of Remdesivir in Adults With Severe COVID-19

NCT04257656 ·Status: TERMINATED ·Phase: PHASE3

Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in China

NCT05682599 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese Participants Compared With Matched, Healthy, Non-Hispanic, Caucasian Participants and to Assess Dose-Proportionality of 3 Doses of Maribavir in Japanese Participants

NCT04497883 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19

NCT04709835 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

NCT04575597 ·Status: COMPLETED ·Phase: PHASE2/PHASE3